PROCAINAMIDE


Synonyms	NSC-27461 Novocainamide Procainamide Procan Procanbid Procapan Pronestyl Pronestyl-SR Sp 100 (pharmaceutical)
Status
Molecule Category	Free-form
ATC	C01BA02
UNII	L39WTC366D
EPA CompTox	DTXSID7023512


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	REQCZEXYDRLIBE-UHFFFAOYSA-N
Smiles	CCN(CC)CCNC(=O)c1ccc(N)cc1
InChI	InChI=1S/C13H21N3O/c1-3-16(4-2)10-9-15-13(17)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H3,(H,15,17)

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C13H21N3O
Molecular Weight	235.33
AlogP	1.34
Hydrogen Bond Acceptor	3.0
Hydrogen Bond Donor	2.0
Number of Rotational Bond	6.0
Polar Surface Area	58.36
Molecular species	BASE
Aromatic Rings	1.0
Heavy Atoms	17.0

Cross References

Resources	Reference
ChEBI	8428
ChEMBL	CHEMBL640
DrugBank	DB01035
DrugCentral	2270
FDA SRS	L39WTC366D
Human Metabolome Database	HMDB0015169
Guide to Pharmacology	4811
KEGG	C07401
PharmGKB	PA451108
PubChem	4913
SureChEMBL	SCHEMBL15914
ZINC	ZINC000001530756

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).